ArticleEpilepsia open2026
Occurrence and clinical correlates of depressive symptoms in adults with epilepsy: A study in Georgia.
Article in Epilepsia open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo evaluate the occurrence, clinical correlates, and screening accuracy of depressive symptoms (DS) among adults with epilepsy in Georgia, a country with limited mental health resources.
methodsWe conducted a cross-sectional study in adults with epilepsy attending a tertiary care center. We assessed DS using two validated tools: the Beck Depression Inventory-II (BDI-II) and the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), combined with comprehensive clinical and demographic data.
resultsTwo hundred and seven adults were included, and DS were identified in 47% using the BDI-II and 22% using the NDDI-E, with moderate agreement between the scales (Cohen's κ = 0.469). DS were associated with later epilepsy onset (median 15.0 vs. 13.5 years), frontal lobe epilepsy (26.3% vs. 8.3%), polytherapy with older ASMs (60.7% vs. 42.3%), and ongoing seizures. SIGNIFICANCE: DS represent a substantial psychiatric burden in adults with epilepsy in Georgia, influenced by epilepsy-related factors and limitations of screening tools. These findings underscore the need for integrated mental health services and routine DS screening in epilepsy care. Longitudinal studies are warranted to clarify causal relationships and inform culturally tailored interventions. PLAIN LANGUAGE SUMMARY: Many people with epilepsy have low mood, but this is often missed and untreated. A recent study in Georgia found that nearly half of people with epilepsy have signs of very low mood. Those who were having regular seizures or taking more medication were more likely to struggle with low mood. In contrast, people who do not have seizures or whose seizures started on the brain's right side showed fewer low mood signs. These findings show that checking mood is just as important as treating their seizures. Routine mental health checks should be part of epilepsy consultations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.